Eurocept B.V. Acquires Lucane Pharma
October 24, 2017
PARIS – Dechert LLP assisted Eurocept B.V. in its acquisition of 100% of Lucane Pharma.
Eurocept is a pharmaceutical company based in the Netherlands and established in 2001. Eurocept develops, registers, produces, distributes, markets and sells medicinal products in therapeutic areas such as anesthesia, oncology, immunology and neurology.
Lucane Pharma is a Paris-based pharmaceutical company active in the field of development, registration and marketing of medicines used in the treatment of rare metabolic diseases. Lucane Pharma is committed to develop new medicines in cooperation with other healthcare professionals in order to make treatment of rare diseases largely available.
The Paris-based team advising Eurocept B.V. included partner François Hellot and associates Guillaume Briant, Sophie Lafay and Benhouda Derradji (corporate); partner Marianne Schaffner and associate Colin Devinant (intellectual property); associates Thibault Meiers and Victoria Hamel (labor and employment); partner Bruno Leroy and associates Chahinez Meddeber and Pierre-Emmanuel Floc’h (tax); and national partner Sophie Pelé (regulatory).
Read the press release in French (PDF): Dechert conseille Eurocept B.V. lors de l’acquisition de Lucane Pharma
About Dechert
Dechert is a global law firm focused on sectors with the greatest complexities and highest regulatory demands. We deliver practical commercial insight and judgment to our clients' most important matters. Nothing stands in the way of giving clients the best of the firm's entrepreneurial energy and seamless collaboration in a way that is distinctively Dechert.
Related Professionals
